Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics, Inc. (CATX) scores 18 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $0. Quantitative score: 38/100. Qualitative score: 10/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full CATX analysis on boothcheck